The Company of Biologists

Title	The Company of Biologists
Class	Professional Publisher (Large)
URL	http://www.biologists.com
Owner	The Company of Biologists is a not-for-profit publisher and UK charity. The Company directors, all biologists, are responsible for the running of the Company (http://www.biologists.com/about-us/).
Address	The Company of Biologists, Bidder Building, Station Road, Histon, Cambridge, CB24 9LF, UK
Copyright and Licensing	http://www.biologists.com/copyright_permissions.html
Copyright and Licensing Policy	Fully Open Access journals Biology Open (BiO) and Disease Models & Mechanisms (DMM): CC-BY (Creative Commons Attribution) licence. Hybrid (subscription and optional Open Access) journals Development (Dev), Journal of Cell Science (JCS), The Journal of Experimental Biology (JEB): Authors retain copyright under exclusive licence; OA articles only: CC-BY
Complaint email	http://www.biologists.com/contact_us.html
Complaint policy	Complaints are handled by the individual journal editorial offices
Publication charge link	http://bio.biologists.org/content/rights-permissions#fee http://dmm.biologists.org/content/rights-permissions#fee http://jcs.biologists.org/content/rights-permissions#open http://dev.biologists.org/content/rights-permissions http://jeb.biologists.org/content/rights-permissions#free
Publication charge policy	The costs of publication in Open Access journals BiO and DMM are covered by charging a fee to the authors or the research supporters for each accepted article. This subsidised fee is $1995 for BiO and £2500 for DMM (plus VAT if applicable). Complete or partial waivers are considered on a case-by-case basis, providing support for authors from developing countries or in genuine financial hardship. Hybrid model journals (Dev, JCS and JEB) offer authors the option of making the full text version of their article immediately accessible upon publication, through payment of a subsidised Open Access fee (£2750 and £3300 for Dev and JCS; plus VAT if applicable). There is no waiver option.
OASPA Compliant OA Journals	2 (Disease Models & Mechanisms and Biology Open)
OA articles approx. number in 12 months	DMM 166; BiO 206; Hybrid journals 175 (2018 data)
Initiatives	Hybrid model journals Dev, JCS and JEB offer authors the option of making the full text version of their articles Open Access for a subsidised fee of £2750 for JEB, and £3300 for Dev and JCS. All articles from the hybrid model journals are made freely available online six months after publication. Our online articles are also freely available to users in developing countries immediately upon publication through the HINARI, AGORA and OARE initiatives. Member of Open Citations Corpus Final published version deposited in US/NLM PMC if mandated by funder or institute. Hybrid journals Dev, JCS and JEB have been afforded Transformative Journals Status according to Plan S criteria (https://www.coalition-s.org/plan-s-compliant-transformative-journals/).
Peer review policy	All journals published by the Company are peer reviewed. Development, JCS, JEB and DMM have adopted a system of cross-referee commenting, whereby referees have a 48 hour window to allow them to comment on each others' reports before the editor makes a decision. Development and JCS have an open system of peer review, whereby reviewer reports, editor decision letters and author response to reviewers can be published alongside each Research article (authors can elect to opt out). All journals integrated with the Publons Reviewer Recognition Service